ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
December 2025
Fusion Science and Technology
November 2025
Latest News
Radium sources yield cancer-fighting Ac-225 in IAEA program
The International Atomic Energy Agency has reported that, to date, 14 countries have made 14 transfers of disused radium to be recycled for use in advanced cancer treatments under the agency’s Global Radium-226 Management Initiative. Through this initiative, which was launched in 2021, legacy radium-226 from decades-old medical and industrial sources is used to produce actinium-225 radiopharmaceuticals, which have shown effectiveness in the treatment of patients with breast and prostate cancer and certain other cancers.
Zongwei Wang, Qi Wang, Xuesen Zhao, Dangzhong Gao, Xiaojun Ma
Fusion Science and Technology | Volume 77 | Number 3 | April 2021 | Pages 188-194
Technical Paper | doi.org/10.1080/15361055.2020.1860417
Articles are hosted by Taylor and Francis Online.
A technique has been developed to characterize the doping concentration distribution of inertial confinement fusion capsules based on a method combining absorption retrieval, computerized tomography, and a gradient doping absorption model. The doping concentration distribution in a reconstructed slice of Si-doped capsules was obtained using this method and on average is in good agreement with contact radiography by comparison experiments. The established technique has been used to obtain a three-dimensional point cloud of the doping concentration distribution by reconstructing all of the slices for the doping capsules. Uncertainty of the doping concentration was analyzed, and the expanded uncertainty is approximately 0.1 at. % (K = 2).